"The R-Pharm group of companies completed the process of registration of the Koronavir, a drug for the treatment of light and moderate forms of COVID-19," TASS reported.
The Koronavir is the third national medicine authorized to fight the pandemic in Russia, a country that has reported 700,792 COVID-19 cases and 10,667 deaths so far.
This new medicine will only be used in hospital conditions and should not be applied to pregnant women, patients with serious liver problems, and people under 18 years of age.
Since 2018, Russia has been fostering companies focused on producing solutions in biotechnology and microbiology.
Fort Boyard of antiviral vaccines
Rostec together with Marathon Group is slated to open research center in Ryazan region, where they will develop live viral vaccines, as well as vaccines for influenza prevention based on cellular technology. pic.twitter.com/Ze2JUQkj7y